NanoCarrier Co. Ltd
NanoCarrier Co., Ltd. researches, develops, produces, and sells pharmaceuticals using micelle nanoparticle technology primarily for the treatment of cancer in Japan. The company's product pipeline includes VB-111 non-proliferative adenovirus vector, which is in phase III clinical trials for the treatment of ovarian cancer, as well as in phase II clinical trials for treatment of rGBM and colorectal cancer; ENT103 Otolaryngology product that is in phase III clinical trials for the treatment of otitis media; NC-6004 Cisplatin micelle, which is in phase II clinical trials for the treatment of head and neck cancer; NC-6300 Epirubicin micelle that is in phase I clinical trials for the treatment of hemangiosarcoma; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma and RUNX1 (mRNA) for osteoarthritis of the knee that are in preclinical stage. The company was founded in 1996 and is headquartered in Tokyo, Japan. Show More...
-
Website https://www.nanocarrier.co.jp
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.75 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 TTM Earnings Per Share JPY -38.75 -36.0 -17.41 -18.85 -30.44 -5.12 -59.53 -62.07 -125.39 -39.14 -26.29 Dividends JPY Payout Ratio % * Shares Mil 13.0 15.0 23.0 26.0 37.0 40.0 43.0 43.0 43.0 46.0 66.0 Book Value Per Share * EUR 0.71 0.76 0.87 2.46 2.47 2.45 2.13 0.95 0.79 1.21 Free Cash Flow Per Share * EUR -0.22 -0.22 -0.12 -0.13 -0.24 -0.27 -0.5 -0.56 -0.74 Return on Assets % -37.14 -34.99 -13.96 -10.45 -11.17 -1.43 -16.86 -18.89 -52.68 -22.33 -17.23 Financial Leverage (Average) 1.12 1.1 1.97 1.27 1.05 1.01 1.27 1.29 1.64 1.46 1.02 Return on Equity % -40.02 -38.78 -21.47 -15.48 -12.38 -1.47 -19.05 -24.11 -73.55 -34.31 -20.76 Return on Invested Capital % -40.18 -38.84 -11.24 -10.84 -11.51 -1.61 -15.78 -19.65 -55.29 -23.5 -20.92 Interest Coverage Current Ratio 8.82 10.46 29.94 36.66 37.39 81.94 61.7 33.66 15.18 39.17 54.91 Quick Ratio 8.38 9.92 28.7 34.56 35.87 80.85 59.84 32.08 14.44 37.95 53.5 Debt/Equity 0.91 0.24 0.04 0.25 0.25 0.53 0.42